Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Multivitamin vs Niacin: they're closely matched on evidence (6 vs 6/10); take care combining them — there's a flagged interaction. Take the 60-second quiz for a pick tailored to your goals.
Multivitamin and Niacin are closely matched across evidence, studies, and safety.
Verdict
Too few graded studies
Top outcomes
Verdict
Probably helps
6 of 11 studies with measurable effects showed benefit.
Top outcomes
1 serving daily (as directed on label, typically 1-2 tablets/capsules)
With breakfast, With lunch (if GI sensitive)
Capsule or softgel
500-2000mg daily for lipid effects; 50-500mg for general health (the cited trials used 1,500 to 2,000 mg a day, none used 50 to 500 mg)
With food (reduces flush), Evening for lipid effects, Split doses for high amounts
Immediate-release niacin (nicotinic acid)
and 7 more not shown
Therapeutic niacin doses far exceed multivitamin contributions. The primary interaction concern is additive hepatotoxicity risk when combining high-dose niacin (especially extended-release) with multivitamins containing additional hepatotoxic-risk nutrients (vitamin A, iron). SAMe depletion may reduce methylation capacity.
At therapeutic niacin doses (500mg+), the multivitamin niacin content is negligible. The clinical concern is avoiding additional hepatotoxic supplements (excess vitamin A, iron) concurrent with therapeutic niacin. Monitor liver function tests every 3–6 months with therapeutic niacin use. Ensure adequate methyl donor support (B12, folate, choline) to compensate for niacin methylation demand.
3-6 months
4-8 weeks
2-6 weeks
6-12 weeks
4-8 weeks
4-8 weeks
30-60 minutes after dose
Effect of multivitamin-mineral supplementation versus placebo on cognitive function: results from the clinic subcohort of the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial and meta-analysis of 3 cognitive studies within COSMOS
The American Journal of Clinical Nutrition (2024) · Meta analysis · n=5203
Pooled 5,203 non-overlapping participants from three cognitive substudies of the COSMOS trial of US adults aged 60 or older: COSMOS-Clinic (573), COSMOS-Mind (2,158) and COSMOS-Web (2,472).
Effects of cocoa extract and a multivitamin on cognitive function: A randomized clinical trial
Alzheimer's & Dementia (2023) · Rct · n=2262
COSMOS-Mind: 2,262 older adults (mean age 73, 60% women) randomised in a 2x2 factorial design to cocoa extract and to a commercial multivitamin-mineral, each versus placebo, for 3 years, with cognition tested by telephone.
Long-term multivitamin supplementation and cognitive function in men: a randomized trial
Annals of Internal Medicine (2013) · Rct · n=5947
5,947 male physicians aged 65 or older in the Physicians' Health Study II, randomised to a daily multivitamin or placebo, with up to 4 telephone cognitive assessments over 12 years.
Niacin for primary and secondary prevention of cardiovascular events
The Cochrane database of systematic reviews (2017) · Meta analysis · n=39195
23 RCTs published between 1968 and 2015 with 39,195 participants were included. The median dose of niacin was 2 g/day.
Effect of lipid-lowering therapies on lipoprotein(a) levels: a comprehensive meta-analysis of randomized controlled trials
Atherosclerosis (2025) · Meta analysis · n=145314
145,314 subjects from 147 RCTs were included.
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Nature medicine (2024) · Cohort
In a discovery cohort of 1,162 stable cardiac patients, niacin metabolism was associated with incident major adverse cardiovascular events.
Both Multivitamin and Niacin are closely matched — the best choice depends on your specific health goals.
For inflammation-related symptoms, Niacin has a higher relevance score (60 vs 15).
Caution: Therapeutic niacin doses far exceed multivitamin contributions. The primary interaction concern is additive hepatotoxicity risk when combining high-dose niacin (especially extended-release) with multivitamins containing additional hepatotoxic-risk nutrients (vitamin A, iron). SAMe depletion may reduce methylation capacity. At therapeutic niacin doses (500mg+), the multivitamin niacin content is negligible. The clinical concern is avoiding additional hepatotoxic supplements (excess vitamin A, iron) concurrent with therapeutic niacin. Monitor liver function tests every 3–6 months with therapeutic niacin use. Ensure adequate methyl donor support (B12, folate, choline) to compensate for niacin methylation demand. Always consult a healthcare provider before combining these supplements.
On Ozempic/Wegovy/Mounjaro? What actually helps — muscle preservation, GI relief, nutrient gaps (no upsell).
Safe, but no benefit if you’re not filling a gap. Who actually needs one — and who doesn’t.
Start with 2–3 foundations, add one at a time, build by goal — without wasting money.
What genuinely lowers LDL/triglycerides — and why "red yeast rice" is a statin in disguise.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.